FMR LLC 13D and 13G filings for Global Blood Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 10:59 am Sale |
2023-02-09 | 13G | Global Blood Therapeutics, Inc. GBT |
FMR LLC | 278,419 0.410% |
-4,318,972 (-93.94%) |
Filing |
| 2022-02-09 09:19 am Purchase |
2022-02-08 | 13G | Global Blood Therapeutics, Inc. GBT |
FMR LLC | 4,597,391 7.099% |
3,370,553 (+274.73%) |
Filing |
| 2021-05-10 1:11 pm Sale |
2021-05-07 | 13G | Global Blood Therapeutics, Inc. GBT |
FMR LLC | 1,226,838 1.970% |
-3,180,227 (-72.16%) |
Filing |
| 2021-02-08 10:23 am Sale |
2021-02-05 | 13G | Global Blood Therapeutics, Inc. GBT |
FMR LLC | 4,407,065 7.131% |
-2,244,230 (-33.74%) |
Filing |